Biomarkers and potential therapeutic targets driving progression of non-alcoholic steatohepatitis to hepatocellular carcinoma predicted through transcriptomic analysis
The core genes may act as critical biomarkers driving the progression of NASH to HCC. They are potential novel targets for the diagnosis and treatment of NASH progression, offering innovative perspectives for its clinical management.
Authors
- Jing Xiong (ORCID: https://orcid.org/0000-0002-9712-6771)
- Huiqing Fan (ORCID: https://orcid.org/0000-0002-1405-9279)
- Bin Wen
- Rong Wang (ORCID: https://orcid.org/0000-0002-2184-6414)
Institutions
- China Pharmaceutical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-12-04
- DOI
- https://doi.org/10.3389/fimmu.2024.1502263
- Citations
- 9
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.48
Funders
- National Natural Science Foundation of China